The antineoplastic potential of a new stable mixed phosphine gold (I) complex containing
tris (tert-butyl) phosphine (tBu3P) and bis (diphenylphosphino) ethene (dppet), namely [Au …

Two dinuclear oxo-bridged organogold (iii) compounds, namely [(N, N, C) 2Au2 (μ-O)][PF6]
2 (with N, N, CH= 6-(1-methylbenzyl)-2, 2′-bipyridine, Au22O1; or 6-(1, 1-dimethylbenzyl) …

A full range of gold compounds is currently being investigated for their potential as anti-
tumor agents. Gold (I) compounds related to the anti-arthritic drug\rm Auranofin^\circledR …

This chapter compiles advances in the investigation of the biological properties of gold
organometallic compounds with possible therapeutic applications, in particular as …

A physiologically stable thiolate gold (I) derivative [Au (Spyrimidine)(PTA-CH2Ph)] Br has
shown inhibition in colon cancer proliferation of Caco-2/TC7, Caco-2/PD7 and HTC-116 …

The reaction of gold reagents [HAuCl4• 3H2O],[AuCl (tht)], or cyclometalated gold (III)
precursor,[C^ NAuCl2] with chiral ((R, R)-(-)-2, 3-bis (t-butylmethylphosphino) quinoxaline) …

The reactivity of three cytotoxic organometallic gold (III) complexes with cyclometalated C, N,
N and C, N ligands (either six-or five-membered metallacycles), as well as that of two …

Gold (III) complexes generally exhibit interesting cytotoxic and antitumor properties, but until
now, their development has been heavily hampered by their poor stability under …

Gold-containing compounds have shown anticancer potential, but their clinical applications
have been severely limited by poor stability and high toxicity in vivo. Here, we report a novel …

Commonly used anticancer drugs are cis platin and other platinum-based drugs. However,
the use of these drugs in chemotherapy causes numerous side effects and the onset of …